The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinomaLiangtao Ye, Enrico N. De Toni|Cell Death Discovery|2019Cited by 60
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and ManagementLiangtao Ye, Florian P. Reiter, Najib Ben Khaled et al.|Liver Cancer|2023Cited by 44
The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4<sup>-/-</sup> Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell PathophysiologyLiangtao Ye, Florian P. Reiter|Aging and Disease|2024Cited by 8